Tower Research Capital (TRC)’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,363
| Closed | -$3.6K | – | 6455 |
|
|
2023
Q2 | $3.6K | Buy |
16,363
+14,779
| +933% | +$3.25K | ﹤0.01% | 5020 |
|
|
2023
Q1 | $0 | Sell |
1,584
-8,046
| -84% | – | ﹤0.01% | 6580 |
|
|
2022
Q4 | $11K | Sell |
9,630
-1,039
| -10% | -$1.19K | ﹤0.01% | 3925 |
|
|
2022
Q3 | $10K | Buy |
10,669
+2,592
| +32% | +$2.43K | ﹤0.01% | 4612 |
|
|
2022
Q2 | $9K | Buy |
8,077
+4,820
| +148% | +$5.37K | ﹤0.01% | 4623 |
|
|
2022
Q1 | $6K | Buy |
3,257
+3,044
| +1,429% | +$5.61K | ﹤0.01% | 4976 |
|
|
2021
Q4 | $0 | Sell |
213
-1,486
| -87% | – | ﹤0.01% | 6787 |
|
|
2021
Q3 | $6K | Buy |
1,699
+647
| +62% | +$2.29K | ﹤0.01% | 4796 |
|
|
2021
Q2 | $8K | Buy |
+1,052
| New | +$8K | ﹤0.01% | 4526 |
|
|
2021
Q1 | – | Sell |
-653
| Closed | -$4K | – | 5857 |
|
|
2020
Q4 | $4K | Buy |
+653
| New | +$4K | ﹤0.01% | 4746 |
|
|
2019
Q3 | – | Sell |
-38
| Closed | – | – | 4654 |
|
|
2019
Q2 | $0 | Buy |
+38
| New | – | ﹤0.01% | 4492 |
|
|
2019
Q1 | – | Sell |
-158
| Closed | -$2K | – | 4461 |
|
|
2018
Q4 | $2K | Sell |
158
-467
| -75% | -$5.91K | ﹤0.01% | 3471 |
|
|
2018
Q3 | $8K | Buy |
+625
| New | +$8K | ﹤0.01% | 2919 |
|